CHMP Okays Kaletra Generic, And Others
This article was originally published in Scrip
The European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion for lopinavir plus ritonavir Mylan, a generic version of Abbvie Inc's HIV drug Kaletra. It is the first generic version of Kaletra to win a CHMP green light in Europe.
Register for our free email digests: